SELP and systemic lupus erythematosus: A recent study revealed that platelets from patients with SLE (SLEDAI: 3.31 ± 4.14) exposed both P‐selectin and the activated form of fibrinogen binding receptor α2bβ3, highlighting platelet activation in patients with SLE despite good control of disease activity [18].